This study evaluated the performance of mass spectrometry (MS), serum protein electrophoresis /immunofixation electrophoresis (IFE), and next-generation flow cytometry (NGF) for detecting minimal residual disease (MRD) in patients with high-risk smoldering multiple myeloma.

Read More> https://multiplemyeloma.pocn.com/patient-management/evaluating-mrd-detection-methods-in-high-risk-smoldering-multiple-myeloma-sensitivity-and-prognosis/